Laddar...
The efficacy and tolerability of mirabegron, a β3 adrenoceptor agonist, in patients with symptoms of overactive bladder
Mirabegron, is the only β-3 adrenoreceptor (AR) agonist available for the treatment of overactive bladder (OAB). To assess the efficacy and tolerability of this novel drug therapy, two phase II and six phase III Astellas-sponsored trials have been conducted with over 10,500 adults with OAB recruited...
Sparad:
| I publikationen: | Ther Adv Urol |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
SAGE Publications
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4707426/ https://ncbi.nlm.nih.gov/pubmed/26834839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215614237 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|